Why point of care testing? The objective of point-of-care testing (POCT) is the rapid provision of diagnostic information to enable clinical decisions to be made at the earliest opportunity during patient care and treatment. Such rapid provision of information facilitates optimistaion of the care process. The potential utility for any application of POCT can therefore be judged in terms of its ...

Nucleic Acid Testing (NAT) promises rapid, sensitive and specific diagnosis of infectious, inherited and genetic disease. The next generation of diagnostic devices will interrogate the genetic determinants of such conditions at the point-of-care, affording clinicians prompt reliable diagnosis from which to guide more effective treatment. The complex biochemical nature of clinical samples, the l...

Point-of-care testing (POCT), or bedside testing is defined as medical testing at or near the site of patient care. In order to approach POCT, a miniaturization system consists of microfluidics chip, bio-recognition probes and electrically sensing element for providing enough information on clinical diagnosis. As the result, multidisciplinary researches and integrations are crucial for developi...

Personalized health care (PHC) includes personalized, preventive, predictive and participatory approaches that are significant in new diagnostics. This personal requires fast, accurate minimally invasive diagnostic tools make it possible to evaluate monitor the process of disease by diagnosing specific biomarkers. Point-of-care testing (POCT) involves a wide range meet this purpose. Electrochem...

OBJECTIVE To investigate the influence of geography on quality control (QC) testing in the point of care testing (PoCT) in general practice trial. DESIGN AND METHODS Within-practice imprecision for QC testing for HbA1c, urine albumin:creatinine ratio, lipids and international normalised ratio was calculated for each geographic region. RESULTS There was no significant difference between the ...

The monthly mean percent positivites for B were 27%, 26%, 29%, and 49% for September, October, November, and December 2013, respectively. We observed 55% positivity for B in January 2014 and 58% for the first 2 weeks of February. Because these percentages were much greater than the national average of <4% [2], we compared the results obtained with the POCT to those obtained with the eSensor res...

OBJECTIVE The use of the levels of hemoglobin A1c for the monitoring of glycemic control in patients with diabetes mellitus (DM) is an accepted method of clinical usefulness. A study was performed to assess the relative costs of hemoglobin A1c determination by diagnostic testing at or near the site of patient care (point-of-care testing, POCT) and using the standard hemoglobin A1c analyzer. MET...

BACKGROUND Point-of-care testing (POCT) devices for determining pre-donation haemoglobin (Hb) concentrations mark the advent of advanced technology for blood banks. POCT devices have undergone several improvements including changes in testing methodology and size of device, befitting the needs of blood donors and blood banks in terms of safety and quality of blood components. This study was pla...